Investigational Site Number :6430001

Saint Petersburg 197758

0 studies enrolling now · 9 studies all time

What they study most

Asthma, Breast Cancer, Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP), Cutaneous Lupus Erythematosus, Relapsing Multiple Sclerosis, Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus, Type 2 Diabetes Mellitus

Studies at this site

• Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion) — Completed
• Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis — Completed
• Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis — Completed
• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early
• Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus — Completed
• Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1) — Completed
• Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine — Completed
• A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus — Completed
• A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps — Completed